Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

4(44.4%)

Phase 1

3(33.3%)

N/A

1(11.1%)

Phase 4

1(11.1%)

9Total

Phase 2(4)

Phase 1(3)

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05137067Phase 2Completed

A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.

Role: lead

NCT06643494Phase 1Suspended

Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical

Role: lead

NCT05410002Phase 1Completed

Diet Effect on Cancer Treatment Outcome

Role: lead

NCT04054505Not ApplicableCompleted

Effectiveness of a Nutraceutical in Raising Circulating Serum Vitamin, Mineral and Amino Acid Levels in Patients.

Role: lead

NCT04141969Phase 2Completed

A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome

Role: lead

NCT04078841Phase 1Completed

Treating Post-Lyme Disease Syndrome With Acetogenins

Role: lead

NCT01987999Phase 2Completed

Eradication of Prostate Cancer Using F-989

Role: lead

NCT03163342Phase 4Completed

Immune Response Following Seasonal Influenza Vaccination

Role: collaborator

NCT02286778Phase 2Completed

Eradication of Malignant Carcinoma in the Breast Tissue

Role: lead

All 9 trials loaded